More evidence for a pathogenic role of NLRP3 inflammasome in T2DM comes from a study reporting that glyburide suppresses inflammasome-mediated IL-1β release in monocytes [190]. The gene discussed is NLRP3; the disease is type 2 diabetes mellitus.